Post di Cellply

⏳Don't miss the opportunity to join our Webinar with Richard Harbottle, Head of DNA Vector Lab at DKFZ German Cancer Research Center, and Massimo Bocchi, Co-founder of Cellply. Hear how the DNA Vector Research Group at German Cancer Research Center (DKFZ) employed VivaCyte to advance their #TCR-T cell research and optimization processes, informed by this in-depth characterization data. 📅 11 July 🕑 08:00 PST | 11:00 EST | 17:00 CEST Sign up here ➡️ https://lnkd.in/djJrr-Vq #Webinar #CellTherapy #TCR

📢On June 28, the kick-off meeting of the project involving Bologna Business School - Università di Bologna master's students in Lifescience & Medtech was held, in collaboration with our R&D department. Good luck students!🍀 #Biotech #Education #CellTherapy

📢Starting tomorrow our colleague Laura Brusa will be at LIT Symposium, organized by LIT - Leibniz Institute for Immunotherapy, presenting our Poster. The poster explains the application of our workflow WF1 on the novel VivaCyte platform powered by the CC-Array® technology for in-depth profiling of the immune system, at the single-cell level. 𝐓𝐡𝐢𝐬 𝐦𝐮𝐥𝐭𝐢𝐩𝐚𝐫𝐚𝐦𝐞𝐭𝐫𝐢𝐜 𝐚𝐧𝐚𝐥𝐲𝐬𝐢𝐬, combining a killing assay with the analysis of immunophenotype on individual cells within a heterogenous population, 𝐜𝐚𝐧 𝐩𝐥𝐚𝐲 𝐚 𝐤𝐞𝐲 𝐫𝐨𝐥𝐞 𝐢𝐧 𝐭𝐡𝐞 𝐞𝐯𝐚𝐥𝐮𝐚𝐭𝐢𝐨𝐧 𝐚𝐧𝐝 𝐬𝐞𝐥𝐞𝐜𝐭𝐢𝐨𝐧 𝐨𝐟 𝐭𝐡𝐞 𝐬𝐩𝐞𝐜𝐢𝐟𝐢𝐜 𝐩𝐫𝐨𝐝𝐮𝐜𝐭𝐬 𝐟𝐨𝐫 𝐮𝐬𝐞 𝐢𝐧 𝐝𝐞𝐯𝐞𝐥𝐨𝐩𝐢𝐧𝐠 𝐚𝐥𝐥𝐨𝐠𝐞𝐧𝐞𝐢𝐜 𝐜𝐞𝐥𝐥 𝐭𝐡𝐞𝐫𝐚𝐩𝐢𝐞𝐬. #CellTherapy #immunophenotype

🌉 The Call4Innovation week has come to an end and we'd like to thank INNOVIT - Italian Innovation and Culture Hub for this opportunity. They were days full of motivation thanks to the interaction with the other companies present and the mentors. This experience represented an important step in accelerating the CellPly North America project! INNOVIT - Italian Innovation and Culture Hub, La Farnesina Ministero degli Affari Esteri, Ambasciata d’Italia a Washington, Consolato Generale a San Francisco, ITA - Italian Trade Agency, Istituto Italiano di Cultura San Francisco #call4innovit #CellTherapy #Innovation #Biotech

🤝🏻Thanks to the collaboration with buildo, we developed a modern and intuitive Graphical User Interface for the VivaCyte software. Designed according to UX and UI best practices, 𝐭𝐡𝐞 𝐬𝐨𝐟𝐭𝐰𝐚𝐫𝐞 𝐞𝐧𝐚𝐛𝐥𝐞𝐬 𝐨𝐮𝐫 𝐜𝐥𝐢𝐞𝐧𝐭𝐬 𝐭𝐨 𝐫𝐮𝐧 𝐞𝐱𝐩𝐞𝐫𝐢𝐦𝐞𝐧𝐭𝐬 𝐚𝐧𝐝 𝐚𝐧𝐚𝐥𝐲𝐳𝐞 𝐝𝐚𝐭𝐚 𝐞𝐚𝐬𝐢𝐥𝐲 𝐚𝐧𝐝 𝐜𝐥𝐞𝐚𝐫𝐥𝐲. 📊 #SoftwareEngineering #UX #UI #CellTherapy

📢Do you want to discover how to deliver next generation single-cell functional analysis and provide actionable insights that are streamlining cell therapy discovery and development? Join our Webinar with Richard Harbottle, Head of DNA Vector Research at DKFZ German Cancer Research Center, and Massimo Bocchi, founder of Cellply. 📅 11 July 🕑 08:00 PST | 11:00 EST | 17:00 CEST Don’t miss this oppotunity! Sign up here ➡️ https://lnkd.in/djJrr-Vq #Webinar #CellTherapy #TCR

🌉Our week in San Francisco for the INNOVIT - Italian Innovation and Culture Hub programme, Call4Innovation, is nearly over. We are among the 15 SMEs selected and we are enthusiastic to participate in this experience and have the opportunity to interact with other startups and entrepreneurs, connect with industry leaders and mentor. INNOVIT - Italian Innovation and Culture Hub, La Farnesina Ministero degli Affari Esteri, Ambasciata d’Italia a Washington, Consolato Generale a San Francisco, ITA - Italian Trade Agency, Istituto Italiano di Cultura San Francisco Istituto Italiano di Cultura San Francisco #call4innovit #CellTherapy #Innovation #Biotech

Thanks to Genenta Science and Pierluigi Paracchi for inviting us to the conference on the 𝙎𝙩𝙧𝙖𝙩𝙚𝙜𝙞𝙘 𝙍𝙤𝙡𝙚 𝙤𝙛 𝘽𝙞𝙤𝙩𝙚𝙘𝙝𝙣𝙤𝙡𝙤𝙜𝙮 𝙛𝙤𝙧 𝙩𝙝𝙚 𝘿𝙚𝙫𝙚𝙡𝙤𝙥𝙢𝙚𝙣𝙩 𝙤𝙛 𝘾𝙤𝙪𝙣𝙩𝙧𝙮 𝙄𝙩𝙖𝙡𝙮, held yesterday in Montecitorio. Operating in the cell therapies sector, it is crucial also for us at Cellply that the Biotech sector becomes a driver for the development of our country. #Biotech #CellTherapy

We’ve been selected by INNOVIT - Italian Innovation and Culture Hub for their project 𝐂𝐚𝐥𝐥𝟒𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧 in the Life Science and Digital Health category. INNOVIT is the first Italian Innovation and Culture Hub in San Francisco, promoted by the Directorate General for the Country System of the Ministry of Foreign Affairs and International Cooperation, in collaboration with the Embassy of Italy in Washington and the Consulate General in San Francisco, and managed with the support of the Italian Trade Agency and the Italian Cultural Institute of San Francisco. Our CEO, Emiliano Spagnolo, and our CSO Massimo Bocchi will participate in the acceleration batch in Silicon Valley, a program that includes mentoring sessions, networking with startups, big tech, venture capital and experts. Find out more ➡️ https://lnkd.in/d9QKaA-4 Thanks for the great opportunity! INNOVIT - Italian Innovation and Culture Hub Ministero degli Affari Esteri e della Cooperazione Internazionale ITA - Italian Trade Agency Istituto Italiano di Cultura San Francisco #call4innovit #CellTherapy #Biotech #Innovation